Actavis Launches U.S. Generic Specialty Injectable Portfolio

News   Jan 16, 2015

 
Actavis Launches U.S. Generic Specialty Injectable Portfolio
 
 
 

RELATED ARTICLES

New Bioprocessing Technique Set to Revolutionize Cell Culture

News

A technique which revolutionises cell culture by allowing the continuous production and collection of cells, has been developed by scientists at Newcastle University. The Newcastle team have developed a coating that allows individual stromal cells to “peel away” from the surface on which they are grown.

READ MORE

Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization

News

Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..

READ MORE

BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences Products

News

BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE